$DXC

DXC (DXC) Q1 2027 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Roger Sachs President and Chief Executive Officer - Raul J. Fernandez Chief Financial Officer - Robert F. Del Bene TAKEAWAYS Total Revenue -- $3 billion, representing a 6.7% organic decline year over year. Adjusted EBIT Margin -- 5.0%, a decrease of 180 basis points year over year reflecting the anticipated revenue profile and seasonal factors.

Original reporting
Published Jul 31, 2026, 4:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 4:45 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
DXC (DXC) Q1 2027 Earnings Call Transcript — source image
Decision brief

The 30-second read

$DXCNeutralMed
01

Why it matters

Traders can update models using the provided FY2027 and Q2 organic revenue decline ranges, adjusted EBIT margin range, EPS range, and FCF guidance, alongside segment book-to-bill and margin commentary.

02

Market read

The earnings call transcript is a decision point for positioning around DXC’s FY2027 revenue downcycle, margin recovery path, and whether AI platform deployments can accelerate contract timelines.

03

What to watch

The transcript cites temporary drags (wind-down of a BPO contract, discretionary IT softness) and litigation-related cash benefits; investors may discount the durability of FCF guidance excluding litigation proceeds.

Relevance 8/10Novelty 7/10Timing: pre-market positioning after the Q1 FY2027 earnings call (July 30, 2026)

Background

DXC’s Q1 FY2027 call focused on transitioning to an agentic AI operating model while managing weakness in discretionary IT infrastructure projects.

Company-level read

Ticker impact

$DXCNeutralMedium confidence
Context

DXC reported Q1 FY2027 revenue of $3.0B, adjusted EBIT margin of 5.0%, and guided FY2027 organic revenue down 3% to 5%.

Expected impact

Near-term trading likely hinges on whether investors believe GIS backlog dynamics and AI platform deployments can offset discretionary IT softness.

Evidence & confidence

The transcript provides multiple forward-looking datapoints (FY2027 revenue, EBIT margin, EPS, FCF, Q2 revenue) plus segment-level book-to-bill and backlog drivers, which can reprice expectations even without a surprise beat.

Market effects

IT services and outsourcing peers may see read-across on discretionary project demand, GIS-style infrastructure softness, and the market’s willingness to underwrite AI-driven contract acceleration.

No explicit regional demand signal beyond segment commentary; likely limited to US-listed IT services sentiment.

Limited direct global macro linkage; AI platform deployment and cloud migration themes are broadly relevant but not quantified by region.

Counterpoint

The book-to-bill improvement (0.99x quarter, trailing 1.0x) may not translate into revenue quickly enough, and GIS profit margin compression (2.6% vs 6.1%) could dominate the narrative.

Key entities

  • DXC Technology

    Reported Q1 FY2027 results and issued FY2027 guidance, including organic revenue decline of 3% to 5% and adjusted EBIT margin of 6.0% to 7.0%.

  • Raul J. Fernandez

    CEO who discussed AI deployment strategy and shortened evaluation cycles for Oasis.

  • Robert F. Del Bene

    CFO who attributed GIS softness to discretionary project timing and discussed segment impacts from contract wind-downs.

Related articles

$DXCMedAI 8/10

DXC’s (NYSE:DXC) Q2 CY2026 Earnings Results: Non

IT services provider DXC Technology (NYSE: DXC) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 5.1% year on year to $3.00 billion. On the other hand, next quarter’s revenue guidance of $2.99 billion was less impressive, coming in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 11.3% below analysts’ consensus estimates. Is now the time to buy DXC? Find out by accessing our full research report, it’s free.

$DXCMedAI 9/10

DXC Technology Co (DXC): Results of Operations and Financial Condition

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dxcfy27q1pressrelease.htm EX-99.1 Document Exhibit 99.1 DXC Technology Reports First Quarter Fiscal Year 2027 Results • Total revenue for Q1 FY27 of $3.00 billion, down 5.1% YoY, down 6.7% on an organic basis (1) • Q1 FY27 Bookings of $3.0 billion, up 5% YoY with a book

$DXCMed

Why is DXC Technology stock rallying today? By Investing.com

DXC Technology shares rose about 4.3% after the company said it partnered with ElevenLabs and participated in ElevenLabs’ $500 million Series D, valuing the AI firm at about $11 billion, according to DXC’s July 28, 2026 press release. The collaboration targets voice AI for service desk, training, and customer service. DXC’s Q1 FY2027 earnings are due July 30.

$DXCMed

DXC launches Private Cloud+ for regulated workloads

DXC Technology launched DXC Private Cloud+, a hybrid private cloud platform for regulated workloads in enterprises and government agencies. It runs on Dell infrastructure and is orchestrated via DXC OASIS, with options for multi-tenant consumption, single-tenant dedicated, and a government edition. DXC targets sectors like financial services, healthcare, manufacturing and public sector; service is generally available.